Mary Parker
Gerontology · Fort Wayne, INNPI 1386661064
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $10,768 of the $13,292 with a category attached, or 81.0%. Sun Pharmaceutical Industries Inc. accounts for 86.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $10,648 and has fallen 96.1% since, to $412 in 2025. Among gerontology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $250.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$12K
- Urovant Sciences Inc$867
- Acadia Pharmaceuticals Inc$315
- Bayer$107
- Sanofi-aventis U.S. LLC$104
- Otsuka America Pharmaceutical, Inc.$92
- plus $261 from 7 others
What the payments were for
- Speaking & faculty fees$10,76881%
- Travel & lodging$8526%
- Food & beverage$1,66713%
- Education$50%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 24 | $11,546 |
| Urovant Sciences Inc | 7 | $867 |
| Acadia Pharmaceuticals Inc | 8 | $315 |
| Bayer | 1 | $107 |
| Sanofi-aventis U.S. LLC | 1 | $104 |
| Otsuka America Pharmaceutical, Inc. | 1 | $92 |
| UCB, Inc. | 1 | $75 |
| Sumitomo Pharma America, Inc. | 3 | $57 |
| Neurocrine Biosciences, Inc. | 2 | $53 |
| Sunovion Pharmaceuticals Inc. | 2 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| GRT US Holding, Inc. | 1 | $18 |
| Novo Nordisk | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DRIZALMA SPRINKLE$11,083
- EZALLOR SPRINKLE$11,083
- KAPSPARGO$10,383
- GEMTESA$818
- NUPLAZID$117
- Kerendia$107
- TZIELD$104
How this compares
$13,292 in reported general payments places this provider in the 95th percentile of 230 gerontology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $39,047 |
| JanuviaSitagliptin Phosphate | 29 | $16,662 |
| XareltoRivaroxaban | 16 | $8,206 |
| MyrbetriqMirabegron | 17 | $6,479 |
| GemtesaVibegron | 26 | $6,300 |
| Atorvastatin Calcium | 192 | $2,537 |
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 22 | $2,360 |
| Levothyroxine Sodium | 200 | $2,266 |
| Metoprolol Succinate | 125 | $2,190 |
| Memantine Hcl | 33 | $1,860 |
| Duloxetine Hcl | 78 | $1,781 |
| Mirtazapine | 62 | $1,780 |
| Lidocaine | 19 | $1,668 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 17 | $1,547 |
| Midodrine Hcl | 31 | $1,383 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $57 | $6,30026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 230 gerontology providers in Indiana.
Other gerontology in Fort Wayne
- Marena ArnoldFort Wayne$8K
- Nikki MannFort Wayne$4K
- Christopher BowmanFort Wayne$4K
- Amanda LutterFort Wayne$3K
- Joyce NwakanmaFort Wayne$1K
- Angela PattiMunster$44K
- Jessica KiszkaMunster$42K
- Sandra GarofaloIndianapolis$24K
- Megan MonnierBloomington$23K
- Diane BrackinFishers$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.